Alveofact Injection
Phospholipids
54mg
LYOMARK PHARMA GmbH
| Pack size | 1 Kit (Powder Vial + Pre-filled Syringe with 1.2ml solvent + 1 caa + 1 vial-adapter) |
|---|---|
| Dispensing mode | POM |
| Source | GERMANY |
| Agent | GULF DRUG EST. |
| Retail Price | 1653.00 AED |
Indications
Alveofact Injection is used for:
Resp distress syndrome (RDS) in premature infants.
Adult Dose
Child Dose
Prevention in premature infant <1250 g birthwt or w/ evidence of surfactant deficiency
Preferably w/in 15 mins of birth.
Rescue Preferably by 8 hr of age.
4 mL/kg birth wt(100 mg of phospholipids/kg birth wt) intratracheally up to 4 doses in 1st 48 hr.
Doses should not be given more frequently than 6 hrly. To be administered as soon as possible.
Renal Dose
Administration
Contra Indications
None known.
Precautions
Infants <600 g birth wt. For intratracheal use only.
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Phospholipids :
Transient bradycardia. O2 desaturation, endotracheal tube reflux & blockage, pallor, vasoconstriction, hypotension, HTN, hypocarbia, hypercarbia & apnea.
Mechanism of Action
Natural bovine pulmonary surfactant; replaces deficient endogenous lung surfactant in neonates with respiratory distress syndrome.
Surfactant prevents the alveoli from collapsing during expiration by lowering surface tension between alveolar surfaces and air.
Note
Alveofact 54mg Injection manufactured by LYOMARK PHARMA GmbH. Its generic name is Phospholipids. Alveofact is availble in United Arab Emirates.
Farmaco UAE drug index information on Alveofact Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Phospholipids :
Suspension (Intratracheal)
Survanta
25mg/ml
ABBVIE Inc.
Suspension (Intratracheal)
Survanta
25mg/ml
ABBVIE Inc.
Capsules (Hard Gelatin)
Essentiale Forte
300mg
A. NATTERMANN & CIE GmbH
Suspension (Intratracheal)
Curosurf
80mg/ml
Cheisi Farmaceutici S.p.A.
Suspension (Intratracheal)
Curosurf
80mg/ml
Cheisi Farmaceutici S.p.A.